Shire LLC
37Patents
32Active
37Granted
53Portfolio score
Filing activity: Jun 26, 2001 → Oct 6, 2014 · 27 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7375083B2 | Pharmaceutical compositions for prevention of overdose or abuse | Human Necessities | 64 | Expired |
| US7678770B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 55 | Active |
| US7671030B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 54 | Active |
| US7655630B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 45 | Active |
| US7662787B2 | Abuse resistant lysine amphetamine compounds | Emerging Cross-Sectional Technologies | 43 | Active |
| US7659253B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 42 | Active |
| US7700561B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 40 | Active |
| US7678771B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7687466B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7723305B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7674774B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7671031B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7718619B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7659254B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 38 | Active |
| US8846100B2 | Controlled dose drug delivery system | Human Necessities | 36 | Active |
| US7375082B2 | Abuse-resistant hydrocodone compounds | Human Necessities | 32 | Expired |
| US7687467B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 25 | Active |
| US7427600B2 | Active agent delivery systems and methods for protecting and administering active agents | Human Necessities | 21 | Expired |
| US7662788B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US7713936B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US8394813B2 | Active agent delivery systems and methods for protecting and administering active agents | Emerging Cross-Sectional Technologies | 13 | Active |
| US7078059B2 | Treatment of bone diseases | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8133881B2 | Carbohydrate conjugates to prevent abuse of controlled substances | Human Necessities | 8 | Active |
| US7622441B2 | Sustained release pharmaceutical compounds to prevent abuse of controlled substances | Human Necessities | 8 | Active |
| US7438900B2 | Dendritic encapsulation of active agents | Performing Operations; Transporting | 6 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.